Trial · NCT07170943
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 21
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Verbal fluency | 12 weeks | Performance on verbal fluency |
| Secondary | Cognitive functioning | 12 weeks | Rey Auditory Verbal Learning Test (RAVLT) |
| Secondary | Cognitive function | 12 weeks | Wechsler Digit Span Task (forward, backward, sequencing) WAIS-IV |
| Secondary | Cognition | 12 weeks | Symbol digit modalities test |
| Secondary | Cognition | 12 weeks | Trail Making Test (TMT) version A and B |
| Secondary | Cognition | 12 weeks | Stroop Color-Word test |
| Secondary | Inflammation - CRP | 12 weeks | Inflammatory blood marker: C-reactive protein |
| Secondary | Inflammation - TNFalpha | 12 weeks | tumor necrosis factor-alpha |
| Secondary | Inflammation - IL6 | 12 weeks | interleukin-6 |
| Secondary | Oxidative stress | 12 weeks | total plasma nitric oxide (NO) |
| Secondary | Oxidative stress | 12 weeks | serum superoxide dismutase (SOD) |
| Secondary | Intestinal health | 12 weeks | Intestinal health markers as measured in blood and feces (microbiota composition, inflammatory fecal markers, microbiota-derived bioactive compounds, intestinal integrity markers |
| Secondary | Metabolic health | 12 weeks | Blood markers of metabolic health: plasma fasting glucose, |
| Secondary | Metabolic health | 12 weeks | Blood markers of metabolic health (plasma fasting glucose, Hb1Ac, triglyceride, adiponectin) |
| Secondary | Metabolic health | 12 weeks | Blood markers of metabolic health: Hb1Ac, |
| Secondary | Metabolic health | 12 weeks | Blood markers of metabolic health: triglyceride |
| Secondary | Metabolic health | 12 weeks | Blood markers of metabolic health: adiponectin |
| Secondary | Mental well-being | 12 weeks | Score on 12-item short form health survey |
| Secondary | Mental well-being | 12 weeks | profiles of mood states-short form (POMS) |
| Secondary | Neurotransmitters | 12 weeks | Levels of plasma neurotransmitters (dopamine, serotonin, (nor)adrenaline, and their metabolites) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07170943/registered